{"id":"NCT01367249","sponsor":"Bausch & Lomb Incorporated","briefTitle":"Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery","officialTitle":"Efficacy and Safety of Bromfenac Ophthalmic Solution vs. Placebo for the Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-05","primaryCompletion":"2011-07","completion":"2011-12","firstPosted":"2011-06-07","resultsPosted":"2014-05-06","lastUpdate":"2014-05-06"},"enrollment":440,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pain","Inflammation","Cataract"],"interventions":[{"type":"DRUG","name":"Bromfenac Ophthalmic Solution","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Bromfenac Ophthalmic Solution","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is an efficacy study of Bromfenac Ophthalmic Solution in cataract surgery.","primaryOutcome":{"measure":"Ocular Inflammation","timeFrame":"Day 15","effectByArm":[{"arm":"Bromfenac Ophthalmic Solution","deltaMin":108,"sd":null},{"arm":"Placebo","deltaMin":53,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":212},"commonTop":["Eye Pain","Anterior Chamber Inflammation","Conjunctival Hyperemia","Photophobia"]}}